Healthcare provider profile · identity verified

Alan Levenson, M.D.

Internal Medicine · BROOKLYN, NY · NPI 1053311464

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	282	73
Amlodipine Besylate	Amlodipine Besylate	262	56
Metoprolol Succinate	Metoprolol Succinate	224	48
Levothyroxine Sodium	Levothyroxine Sodium	161	39
Omeprazole	Omeprazole	161	37
Eliquis	Apixaban	141	22
Lisinopril	Lisinopril	124	26
Losartan Potassium	Losartan Potassium	99	26
Metformin Hcl Er	Metformin Hcl	97	24
Simvastatin	Simvastatin	93	19
Rosuvastatin Calcium	Rosuvastatin Calcium	92	25
Zolpidem Tartrate	Zolpidem Tartrate	87	24
Gabapentin	Gabapentin	72	14
Pantoprazole Sodium	Pantoprazole Sodium	71	19
Sertraline Hcl	Sertraline Hcl	66	11
Xarelto	Rivaroxaban	64	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	62	15
Carvedilol	Carvedilol	56	suppressed
Cephalexin	Cephalexin	55	27
Furosemide	Furosemide	54	15
Famotidine	Famotidine	52	11
Memantine Hcl	Memantine Hcl	51	suppressed
Potassium Chloride	Potassium Chloride	49	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	48	15
Torsemide	Torsemide	48	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	47	15
Finasteride	Finasteride	47	15
Januvia	Sitagliptin Phosphate	45	suppressed
Ozempic	Semaglutide	44	suppressed
Clopidogrel	Clopidogrel Bisulfate	43	11
Methenamine Hippurate	Methenamine Hippurate	43	suppressed
Alprazolam	Alprazolam	42	suppressed
Glimepiride	Glimepiride	41	12
Linzess	Linaclotide	41	suppressed
Ramipril	Ramipril	41	11
Metoprolol Tartrate	Metoprolol Tartrate	40	suppressed
Cefdinir	Cefdinir	39	35
Venlafaxine Hcl Er	Venlafaxine Hcl	38	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	36	suppressed
Synthroid	Levothyroxine Sodium	35	12
Cefuroxime	Cefuroxime Axetil	33	31
Clonazepam	Clonazepam	33	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	33	suppressed
Donepezil Hcl	Donepezil Hcl	30	suppressed
Enalapril Maleate	Enalapril Maleate	29	suppressed
Spironolactone	Spironolactone	29	suppressed
Mounjaro	Tirzepatide	28	suppressed
Ezetimibe	Ezetimibe	27	suppressed
Metformin Hcl	Metformin Hcl	27	suppressed
Mirtazapine	Mirtazapine	27	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	27	11
Ranolazine Er	Ranolazine	26	suppressed
Pravastatin Sodium	Pravastatin Sodium	24	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Tresiba Flextouch U-200	Insulin Degludec	24	suppressed
Brilinta	Ticagrelor	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	20	suppressed
Ketoconazole	Ketoconazole	19	11
Telmisartan	Telmisartan	19	suppressed
Trazodone Hcl	Trazodone Hcl	19	suppressed
Allopurinol	Allopurinol	18	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	18	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Atenolol	Atenolol	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	15
Farxiga	Dapagliflozin Propanediol	15	suppressed
Prednisone	Prednisone	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	12
Jardiance	Empagliflozin	14	suppressed
Mycophenolate Mofetil	Mycophenolate Mofetil	14	suppressed
Bumetanide	Bumetanide	13	suppressed
Colchicine	Colchicine	13	suppressed
Digoxin	Digoxin	13	suppressed
Icosapent Ethyl	Icosapent Ethyl	13	suppressed
Irbesartan	Irbesartan	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Vascepa	Icosapent Ethyl	13	suppressed
Clonidine	Clonidine	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Prasugrel Hcl	Prasugrel Hcl	12	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Lorazepam	Lorazepam	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error